Laurus Labs Limited — Updates, 24-01-2025: Press Release

Laurus Labs has reported strong financial results for the quarter and nine months ended December 31, 2024. Revenues reached ₹1,415 Cr for Q3, reflecting an 18% increase year-over-year, while nine-month revenues totaled ₹3,834 Cr, up 6%. The EBITDA for Q3 stood at ₹285 Cr with an impressive margin of 20.1%, showing a 56% growth compared to the same quarter last year. For the nine months, EBITDA was ₹638 Cr, marking an 18% increase, and the EBITDA margin improved to 16.6%.

The CDMO segment showed significant growth, with revenues increasing by 89% year-over-year to ₹400 Cr in Q3 and 33% to ₹913 Cr for the nine-month period. Conversely, the API segment saw a slight decline, attributed to lower demand, but is expected to rebound next year. The company’s strategic focus on high-value CMO and CDMO opportunities remains intact, with ongoing capital investments aimed at supporting long-term growth. Overall, Laurus Labs presents a positive outlook, supported by robust performance and a healthy order book.